Duodenoscope manufacturer Olympus Medical Systems Group is facing $85m in penalties after pleading guilty to charges of distributing misbranded medical devices.
The US Department of Justice says that Olympus, as well as senior executive Hisao Yabe, failed to submit adverse event...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?